
Tylenol In Pregnancy Linked To Female Reproductive Damage & Smaller Ovaries In Their Daughters
Episode 666
A landmark 2026 study links Tylenol use while pregnant to 41% smaller ovaries, 23% fewer ovarian follicles, and 13% smaller uteruses in infant girls. It is the latest research on the effects of acetaminophen, following explosive allegations by HHS Secretary Robert F. Kennedy Jr. that connected the popular OTC painkiller to autism & ADHD. Published in Human Reproduction Open, the study followed 302 infant girls, measured acetaminophen in their mothers’ urine, and examined the girls by ultrasound. The authors describe it as the first human cohort designed specifically to study prenatal acetaminophen exposure and ovarian development. The doses were not extreme: the median total reported dose across pregnancy was about 3 grams. The study reports a dose-response pattern, and a separate cohort of 1,210 girls showed lower uterine and ovarian volume at puberty. The authors note the design is observational and cannot establish causation. Dr. Kelly Victory and epidemiologist Nicolas Hulscher join Dr. Drew to examine the findings and discuss pharma’s historic overmedication of women – now at the forefront of the Lindsay Clancy trial. Hulscher also presents new case report data showing Pfizer COVID-19 vaccine plasmid DNA recovered from a lethal “turbo cancer” heart tumor. Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company with over 30 years of clinical experience.
Publisher
Ask Dr. Drew
Link
drdrew.com/2026/new-study-tylenol-in-pregnancy-linked-to-female-reproductive-damage-smaller-ovaries-in-their-daughters-ask-dr-drew/
Published
September 16, 2026
Duration
1h 10m
Format
Podcast
Category
News · News Commentary
Source
RSS feed
Host
Dr. Drew
Ask Dr. Drew
@askdrdrew
#pregnancylinked #femalereproductivedamage #smallerovaries
